Dupixent Rejected by FDA for Hives Disorder

Dupixent Fails to Win FDA Approval for Hives Disorder, Needs More Data

Anika Sharma

Regeneron and Sanofi have faced an unexpected hurdle in their pursuit of regulatory approval for Dupixent, a monoclonal antibody aimed ...

Skyrizi Dominates Drug Ads as Others Cut Spending

How Skyrizi Outspent Other Drugs in a Tough Market

SG Tylor

In July, AbbVie’s Skyrizi maintained its position as the top pharma drug ad spender for the second consecutive month, but ...

Sanofi’s Q2: 3 Launches, Dupixent on Track for €10B

Sanofi Reports ‘Solid’ Q2 Performance with 3 Ongoing Launches and Dupixent Nearing €10B Milestone

SG Tylor

Sanofi, a leading pharmaceutical company, is navigating the challenges posed by the entry of generic versions of its drug Aubagio ...